10x Genomics, Inc. — Director's Dealing 2021

Dec 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-12-28

Reporting Person: Hindson Benjamin J. (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-28	Class A Common Stock	M	53952	$1.07	Acquired	100718	Direct
2021-12-28	Class A Common Stock	M	59968	$1.20	Acquired	160686	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-28	Stock Option (right to buy)	$1.07	M	53952	Disposed	2026-11-18	Class A Common Stock (53952)	Direct
2021-12-28	Stock Option (right to buy)	$1.20	M	59968	Disposed	2027-10-18	Class A Common Stock (59968)	Direct

Footnotes

F1: All of the shares subject to the option are fully vested and exercisable as of the date hereof.